U.S. Industrials Stock News

NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies (HIMX) Margin Compression Challenges Bullish Earnings Growth Narrative

Himax Technologies (HIMX) closed FY 2025 with fourth quarter revenue of US$203.1 million and basic EPS of US$0.07, alongside net income of US$6.3 million, setting a clear marker for how the year wrapped up. Over recent periods the company has seen quarterly revenue move from US$237.2 million and EPS of US$0.14 in Q4 2024 to US$215.1 million and EPS of US$0.11 in Q1 2025, US$214.8 million and EPS of US$0.09 in Q2, and US$199.2 million and EPS of US$0.01 in Q3, before landing at the latest Q4...
NYSE:YELP
NYSE:YELPInteractive Media and Services

Yelp (YELP) Margin Improvement Reinforces Bullish Profitability Narratives Despite Slower Growth Forecasts

Yelp FY 2025 earnings snapshot Yelp (YELP) closed FY 2025 with fourth quarter revenue of US$360.0 million and basic EPS of US$0.62, alongside net income of US$37.8 million, setting the tone for a year in which trailing twelve month revenue reached about US$1.5 billion and EPS came in at US$2.30. Over the past six quarters, the company has seen quarterly revenue move between US$358.5 million and US$376.0 million, while basic EPS ranged from US$0.37 to US$0.69, giving you a clear line of sight...
NYSE:AAP
NYSE:AAPSpecialty Retail

Advance Auto Parts (AAP) Same Store Sales Rebound Tests Profitability Turnaround Narratives

Latest earnings snapshot and why it matters for the AAP story Advance Auto Parts (AAP) just posted third quarter FY 2025 revenue of about US$2.0 billion with basic EPS near breakeven at roughly US$0.02 loss, setting a cautious tone after a run of mixed results. The company has seen quarterly revenue move from US$2.18 billion in the second quarter of FY 2024 to US$2.58 billion in the first quarter of FY 2025, while basic EPS has swung from a US$10.20 loss in the fourth quarter of FY 2024 to a...
NYSE:WPC
NYSE:WPCREITs

W. P. Carey’s €1b Notes Reshape Debt Profile And Portfolio Mix

W. P. Carey (NYSE:WPC) has completed a €1b senior unsecured note offering. The euro denominated notes are intended to help manage existing debt and fund new investments. The company is reshaping its portfolio, including acquisitions, property sales, and an exit from self storage and office assets. W. P. Carey runs a diversified net lease real estate portfolio, where tenants typically handle many property level costs. The latest financing move comes as the company adjusts its mix of...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Holdings (PLMR) Earnings Surge 67.6% And Reinforce Bullish Profitability Narratives

Palomar Holdings FY 2025 earnings snapshot Palomar Holdings (PLMR) has capped FY 2025 with fourth quarter revenue of US$253.4 million and basic EPS of US$2.12, rounding out a year in which trailing twelve month revenue reached US$876.0 million and EPS came in at US$7.40 on net income of US$197.1 million. Over the past few quarters the company has seen revenue move from US$174.6 million and EPS of US$1.61 in Q1 2025 to US$253.4 million and EPS of US$2.12 in Q4, with Q3 sitting at US$244.7...
NYSE:PDM
NYSE:PDMOffice REITs

Piedmont Realty Trust Q4 FFO Drop Tests Bullish Cash Flow Narratives

Piedmont Realty Trust FY 2025 earnings snapshot Piedmont Realty Trust (PDM) has just posted its FY 2025 numbers, with fourth quarter revenue of US$142.9 million and basic EPS of a US$0.35 loss, alongside funds from operations of US$14.4 million. Over recent quarters the company has seen revenue move between US$139.2 million and US$143.2 million, while basic EPS has ranged from a US$0.08 loss to a US$0.35 loss. This gives a clear view of how the top line and per share results have tracked into...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

Corsair Gaming (CRSR) Valuation Check After Earnings, 2026 Guidance And New Share Buyback

What Corsair just told the market Corsair Gaming (CRSR) has packed a lot into its latest update, combining Q4 and full year 2025 results with fresh 2026 guidance and a new US$50 million share buyback plan. For Q4 2025, Corsair reported sales of US$436.86 million and net income of US$25.79 million, with basic earnings per share from continuing operations at US$0.23 and diluted earnings per share at US$0.22. Across 2025 as a whole, sales were US$1.47 billion, while the company recorded a net...
NYSE:GNRC
NYSE:GNRCElectrical

Generac Holdings Q4 Loss And Margin Compression Test High P/E Growth Narrative

Generac Holdings (GNRC) closed out FY 2025 with Q4 revenue of US$1.1b and a basic EPS loss of US$0.42, as net income excluding extra items came in at a loss of US$24.5m, setting a cautious tone around profitability. The company has seen quarterly revenue move from US$1.23b in Q4 2024 to US$1.1b in Q4 2025, while basic EPS shifted from US$2.18 a year ago to a loss of US$0.42, and trailing 12 month EPS eased from US$5.46 in Q4 2024 to US$2.73 in Q4 2025, which leaves investors weighing softer...
NYSE:BAP
NYSE:BAPBanks

Credicorp’s Mibanco SaaS Upgrade With Temenos And What It Signals For Valuation

Mibanco, the microfinance arm of Credicorp (NYSE:BAP), is partnering with Temenos to modernize its core banking platform using software as a service. The collaboration focuses on faster product launches, improved customer experience, and broader financial inclusion for small businesses in Peru. For Credicorp, which has a strong presence in microfinance through Mibanco, this tech upgrade relates directly to how banking services are delivered to small and midsize enterprises in Peru. The move...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Reassessing Omnicell (OMCL) After Sharp Multi‑Year Share Price Declines

If you are wondering whether Omnicell's current share price really reflects its potential, this article will walk through how the stock stacks up on value. The shares most recently closed at US$36.18, after returns of a 7.4% decline over 7 days, 29.6% decline over 30 days, 19.8% decline year to date, 10.1% decline over 1 year, 33.5% decline over 3 years, and 72.1% decline over 5 years. Recent news coverage around Omnicell has focused on the company as part of broader discussions about...
NasdaqGS:CFLT
NasdaqGS:CFLTSoftware

Confluent (CFLT) Revenue Growth Versus Persistent Losses Tests High Multiple Narratives

Confluent (CFLT) just wrapped up FY 2025 with Q4 revenue of US$314.8 million and a basic EPS loss of US$0.23, while trailing twelve month revenue sat at about US$1.17 billion against a full year basic EPS loss of US$0.86. Over recent quarters, the company has seen revenue move from US$261.2 million in Q4 2024 to US$314.8 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.19 and US$0.27. The latest print keeps the spotlight firmly on how quickly revenue growth can offset...
NYSE:PMT
NYSE:PMTMortgage REITs

Is PennyMac Mortgage Investment Trust (PMT) Pricing Look Stretched After Recent Share Price Weakness

If you are wondering whether PennyMac Mortgage Investment Trust is offering good value at its recent share price, you are not alone. This article is designed to help you make sense of that question. The stock most recently closed at US$12.49, with returns of 2.0% over the past week, a 5.2% decline over the past month, a 1.3% decline year to date, and a 3.4% return over the last year, alongside cumulative returns of 26.2% over three years and 22.1% over five years. Recent coverage has focused...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta’s SRP-1005 Trial Approval Opens New Huntington’s Disease Opportunity

Sarepta Therapeutics (NasdaqGS:SRPT) received Medsafe approval in New Zealand for its first-in-human clinical trial of SRP-1005. SRP-1005 is an investigational siRNA therapeutic targeting Huntington's Disease, a severe neurodegenerative condition. The authorization allows Sarepta to begin a Phase 1 study, marking its clinical entry into Huntington's Disease research. Sarepta Therapeutics is best known for its Duchenne muscular dystrophy franchise, and SRP-1005 broadens its rare disease...
NYSE:CNR
NYSE:CNROil and Gas

Core Natural Resources (CNR) Returns To Quarterly Profit Challenging Bearish Narratives On Coal Risks

Core Natural Resources (CNR) has posted a mixed set of FY 2025 numbers, with Q3 revenue at about US$1.0 billion and basic EPS of US$0.61 alongside a trailing twelve month loss of US$43.4 million on basic EPS of US$0.94. The company has seen quarterly revenue move from US$553.4 million in Q3 2024 to more than US$1.0 billion in Q3 2025, while basic EPS has swung between a profit of US$3.23 and a loss of US$1.38 over that stretch. This highlights how volatile margins have been. For investors,...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Returns And A 13.9% Undervaluation Narrative

What is moving Amphastar Pharmaceuticals now? Amphastar Pharmaceuticals (AMPH) has drawn investor attention after its recent share performance, with the stock around $27.55 and short term returns mixed between the past week, month and past 3 months. See our latest analysis for Amphastar Pharmaceuticals. At around $27.55, Amphastar Pharmaceuticals has given investors a mixed ride, with recent share price returns over the past week and month soft, while the 90 day share price return of 5.72%...
NasdaqGS:PCH
NasdaqGS:PCHSpecialized REITs

Is PotlatchDeltic’s NASDAQ Composite Exit Quietly Reframing the Investment Case for PCH?

In early February 2026, PotlatchDeltic Corporation was removed from the NASDAQ Composite Index, while multiple long-running ESOP-related shelf registrations for common stock were formally closed. This combination highlights how a technical index change, rather than routine employee stock plan administration, can have an outsized influence on trading flows and investor attention. Next, we’ll examine how PotlatchDeltic’s removal from the NASDAQ Composite Index could affect its existing...
NYSE:IEX
NYSE:IEXMachinery

How Strong Q4 Results and Innovation Reshuffle Could Shape IDEX’s (IEX) Long-Term Strategy

IDEX Corporation recently reported fourth-quarter 2025 results showing higher sales of US$899.1 million and net income of US$128.3 million, while also continuing its long-running share repurchase program. Soon after these results, IDEX moved to eliminate the role of Senior Vice President, Chief Strategy and Innovation Officer Roopa Unnikrishnan, signaling an organizational shift in how it approaches growth and innovation. We’ll now consider how the stronger quarter, especially momentum in...
NYSE:SLVM
NYSE:SLVMForestry

Sylvamo (SLVM) Margin Compression To 5.2% Tests Bullish Valuation Narratives

Sylvamo (SLVM) just posted its FY 2025 third quarter numbers, reporting revenue of US$846 million and basic EPS of US$1.43 alongside net income of US$57 million. The company’s quarterly revenue moved from US$970 million in Q4 2024 to US$821 million in Q1 2025, US$794 million in Q2, and then US$846 million in Q3. Over the same period, basic EPS went from US$1.98 to US$0.67, US$0.37, and then US$1.43. These shifts give investors more detail for evaluating how recent performance trends relate to...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

3 Stocks That May Be Trading Up To 42.2% Below Estimated Intrinsic Value

As February begins, the United States stock markets have shown strong performance, with major indices like the Dow Jones Industrial Average and S&P 500 experiencing significant gains. This positive momentum in the market presents an opportunity to explore stocks that may be undervalued, potentially trading below their estimated intrinsic value. Identifying such stocks requires a keen understanding of current market conditions and economic indicators to evaluate their true potential amidst...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Insider Backed Growth Leaders Unveiled

As February begins, U.S. stock markets have shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting positive investor sentiment amid economic developments such as a new trade deal with India. In this thriving market environment, companies that exhibit high insider ownership often signal confidence from those who know the business best, making them potentially attractive options for growth-focused investors seeking...
OTCPK:BUKS
OTCPK:BUKSAerospace & Defense

Spotlight On February 2026's Promising Penny Stocks

As February 2026 begins, major U.S. stock indexes have shown robust performance, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs. This market momentum sets a promising backdrop for exploring investment opportunities in various sectors. Despite its somewhat outdated terminology, the concept of penny stocks remains significant as these smaller or newer companies can offer a blend of affordability and growth potential when backed by strong financials...